BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Demyelinating Diseases

Below is an extended Demyelinating Diseases research listing. Click here to return to the Demyelinating Diseases main in depth entry.

Recent Publications on Demyelinating Diseases:

Influence of anxiety and reported stressful life events on relapses in multiple sclerosis: a prospective study.
Objective Self-reported stressful life events and infections have been...
Direct Link
30th August, 2008
Department of Neurology, University of Athens School of Medicine, Unit of
[Current stage of fMRI applications in newborns and children during the first year of life]
Currently, a paradigm shift towards expanded early use of cranial MRI in...
Direct Link
30th August, 2008
Radiologische Universitatsklinik Bonn, FE Klinische Funktionelle
Combination therapy of lovastatin and rolipram provides neuroprotection and promotes neurorepair in inflammatory demyelination model of multiple sclerosis.
Drug combination therapies for central nervous system (CNS) demyelinating...
Direct Link
23rd August, 2008
Department of Pediatrics, Medical University of South Carolina,
Current concepts in the diagnosis of transverse myelopathies.
The clinical symptoms and MRI characteristics of transverse myelopathy...
Direct Link
23rd August, 2008
Referral Center for Demyelinating diseases of the Central Nervous System,
Acute hemorrhagic demyelination in a murine model of multiple sclerosis.
Acute hemorrhagic leukoencephalomyelitis (AHLE) is a rare neurological...
Direct Link
22nd August, 2008
Department of Neurology and Neuroscience, University of Cincinnati,
Intrathecal anti-alphaB-crystallin IgG antibody responses: potential inflammatory markers in Guillain-Barre syndrome.
OBJECTIVE: alphaB-crystallin (alphaBC), a small stress protein with...
Direct Link
21st August, 2008
Clinical Department of Neurology, Innsbruck Medical University,
Glial precursor cell transplantation therapy for neurotrauma and multiple sclerosis.
Traumatic injury to the brain or spinal cord and multiple sclerosis (MS)...
Direct Link
19th August, 2008
Krembil Neuroscience Centre, Toronto Western Research Institute, 399
The demyelinating diseases.
Traumatic injury to the brain or spinal cord and multiple sclerosis (MS)...
Direct Link
16th August, 2008
Refferal Center for Demyelinating Diseases of the Central Nervous System,
Disseminated encephalomyelitis in adults.
Disseminated encephalomyelitis (DEM) is an inflammatory demyelinating...
Direct Link
16th August, 2008
Department of Neurology, Reffered Center for Demyelinating Diseases of
Stem cell-based strategies for treating pediatric disorders of myelin.
The pediatric leukodystrophies comprise a category of disease manifested...
Direct Link
13th August, 2008
Division of Cell and Gene Therapy and Center for Translational
Celiac antibodies in the diagnostic workup of white matter lesions.
The pediatric leukodystrophies comprise a category of disease manifested...
Direct Link
5th August, 2008
Cecilie Vogt Clinic for Neurology in the HKBB, Charite-University Medicine
Mast cell activation by myelin through scavenger receptor.
A role for mast cells (MC) in the pathogenesis of multiple sclerosis (MS)...
Direct Link
29th July, 2008
Department of Physiology and Pathology, University of Trieste, via A.
Myelination competent conditionally immortalized mouse Schwann cells.
Numerous mouse myelin mutants are available to analyze the biology of the...
Direct Link
29th July, 2008
Neurogenetics Laboratory, Academic Medical Center, P.O. Box 22700,
Galectin-3/MAC-2, Ras and PI3K activate complement receptor-3 and scavenger receptor-AI/II mediated myelin phagocytosis in microglia.
The removal of degenerated myelin is essential for repair in Wallerian...
Direct Link
11th July, 2008
Department of Anatomy and Cell Biology, Hebrew University Faculty of
Chromatic discrimination losses in multiple sclerosis patients with and without optic neuritis using the Cambridge Colour Test.
We assessed chromatic discrimination in multiple sclerosis (MS) patients...
Direct Link
5th July, 2008
Depto. Psicologia Experimental, Instituto de Psicologia, Universidade de
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional